Ilan Shimon1. 1. Rabin Medical Center, Institute of Endocrinology and Metabolism, Beilinson Hospital, 49100, Petach Tikva, Israel, ilanshi@clalit.org.il.
Abstract
INTRODUCTION: Cushing's syndrome (CS) is a rare disease characterized by a collection of signs and symptoms, also common in the general population without elevated cortisol secretion. During the last years more patients with CS are identified earlier and with milder disease. Many of these patients are diagnosed during screening efforts performed for certain or isolated complaints like weight gain, diabetes mellitus (DM), hypertension, osteoporosis, elevated white blood cell counts and more. METHODS: In this review article the most popular screening test performed in the studies cited was the 1-mg dexamethasone suppression test. CONCLUSIONS: Cushing is not frequent enough to support the use of routine screening in patients with morbid obesity and type 2 DM. Also only 1% of hypertensive patients have secondary hypertension due to CS. However, screening should be considered in young patients with resistant DM and/or hypertension. Among patients with osteoporosis and vertebral fractures up to 5% were diagnosed with subclinical hypercortisolism; most of these had adrenal adenoma. Screening for CS is important in subjects with adrenal incidentaloma, and many studies show a high prevalence (~10%) of Cushing or subclinical CS in these patients.
INTRODUCTION:Cushing's syndrome (CS) is a rare disease characterized by a collection of signs and symptoms, also common in the general population without elevated cortisol secretion. During the last years more patients with CS are identified earlier and with milder disease. Many of these patients are diagnosed during screening efforts performed for certain or isolated complaints like weight gain, diabetes mellitus (DM), hypertension, osteoporosis, elevated white blood cell counts and more. METHODS: In this review article the most popular screening test performed in the studies cited was the 1-mg dexamethasone suppression test. CONCLUSIONS: Cushing is not frequent enough to support the use of routine screening in patients with morbid obesity and type 2 DM. Also only 1% of hypertensivepatients have secondary hypertension due to CS. However, screening should be considered in young patients with resistant DM and/or hypertension. Among patients with osteoporosis and vertebral fractures up to 5% were diagnosed with subclinical hypercortisolism; most of these had adrenal adenoma. Screening for CS is important in subjects with adrenal incidentaloma, and many studies show a high prevalence (~10%) of Cushing or subclinical CS in these patients.
Authors: K Mullan; N Black; A Thiraviaraj; P M Bell; C Burgess; S J Hunter; D R McCance; H Leslie; B Sheridan; A B Atkinson Journal: J Clin Endocrinol Metab Date: 2010-03-17 Impact factor: 5.958
Authors: Raluca Trifanescu; Mara Carsote; Andra Caragheorgheopol; Dan Hortopan; Anda Dumitrascu; Mariana Dobrescu; Catalina Poiana Journal: Maedica (Buchar) Date: 2013-06
Authors: M Paja; I Merlo; J Rodríguez-Soto; E Cruz-Iglesias; M D Moure; C Elías; A Oleaga; N Egaña Journal: J Endocrinol Invest Date: 2022-08-09 Impact factor: 5.467
Authors: Leah T Braun; Frederick Vogel; Stephanie Zopp; Thomas Marchant Seiter; German Rubinstein; Christina M Berr; Heike Künzel; Felix Beuschlein; Martin Reincke Journal: J Clin Endocrinol Metab Date: 2022-08-18 Impact factor: 6.134
Authors: Leah T Braun; Anna Riester; Andrea Oßwald-Kopp; Julia Fazel; German Rubinstein; Martin Bidlingmaier; Felix Beuschlein; Martin Reincke Journal: Front Endocrinol (Lausanne) Date: 2019-11-08 Impact factor: 5.555